About the research
CORS² addresses key regulatory science challenges by integrating strong regulatory science research expertise with multidisciplinary approaches, real-world pharmacoepidemiological studies, advanced data science methods, and state-of-the-art pharmacovigilance methodologies. CORS² research spans three interconnected groups, united by a shared commitment to generating actionable evidence for regulatory decision-making and public health.
CORS² Representative
Christine Erikstrup Hallgreen
Associate Professor

Research groups
Research areas include proactive surveillance and signal detection using big healthcare data, multi-database network studies of rare adverse events, and the design of rapid risk evaluation systems. The group actively exploits the Danish National Registers and collaborates through the Pharmacoepidemiology Research Collaboration (PRC) and the Nordic PharmacoEpidemiological Network (NorPEN).
Key research areas include AI-driven causality assessment, signal detection and validation across major spontaneous reporting databases (EudraVigilance, FAERS, VAERS, VigiBASE), applied precision medicine using causal machine learning, and pre-symptomatic care through AI-enabled early detection. The group holds close partnerships with industry and regulatory agencies.
Research encompasses regulatory methodology, benefit-risk assessment, and the development of frameworks to support robust, evidence-based pharmaceutical regulation in Denmark, the EU, and internationally.
Mission & Vision 2026-2029
Vision
CORS² envisions a resilient, science-driven regulatory ecosystem that ensures rapid, safe access to innovative treatments while upholding the highest standards of safety, efficacy, and quality. Through interdisciplinary research, education, and strategic partnerships, CORS² aims to shape the future pharmaceutical regulatory and real-world evidence environment in Denmark, the EU, and across the globe—cultivating new experts and informing policy with sound, evidence-based guidance.
Mission
CORS² aims to be a leading Center dedicated to research, education, and collaboration in pharmaceutical regulatory science. By integrating real-world epidemiological and pharmacovigilance studies, advanced data science methods and regulatory science - we support evidence-based regulatory decision-making, enhance public health, and drive pharmaceutical innovation.
Education & Talent Development
Teach core curriculum in Regulatory Sciences, Pharmacovigilance and Pharmacoepidemiology to students of Pharmaceutical sciences. Ensuring at least one-third of MSc graduates in Pharmacy at UCPH complete specialized CORS² courses. We actively develop the "DETERMINANT" Erasmus Mundus Joint Master's program.
Example of master´s theses projects:
AI driven Pharmacovigilance and Pharmacoepidemiology
Employees
- Professor
- Professor
- Associate Professor
- Associate Professor
